Biomarkers in aneurysmal subarachnoid hemorrhage: A short review

Batista S.; Bocanegra-Becerra J.E.; Claassen B.; Rubião F.; Rabelo N.N.; Figueiredo E.G.; Oberman D.Z. · World Neurosurgery: X (2023) · DOI: 10.1016/j.wnsx.2023.100205

Resumen

Poor outcomes of aneurysmal subarachnoid hemorrhage (aSAH) can be the result of the initial catastrophic event or the many acute or delayed neurological complications. Recent evidence suggests that some molecules play a critical role in both events, through some unknown pathways involved. Understanding the role of these molecules in these events could allow to improve diagnostic accuracy, guide management, and prevent long-term disability in aSAH. Here we present the studies on aSAH biomarkers present in current medical literature, highlighting their roles and main results.

Instituciones: Universidad Peruana Cayetano Heredia